1-3 of 3
Eva Baigorri
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Detection of Minimal Residual Disease in Autograft Is Prognostic of Survival Following Stem Cell Transplant in Multiple Myeloma

Michael P. Chu, MD, Eva Baigorri, Jitra Kriangkum, PhD, Joanne D. Hewitt, NP, PhD, Andrew Belch, Christopher P. Venner, Irwindeep Sandhu, MDFRCPC, Linda M. Pilarski, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1928.
https://doi.org/10.1182/blood.V130.Suppl_1.1928.1928
Published: 2017
Journal Articles

Ex Vivo Modeling of Multiple Myeloma Provides Basis for Studying Treatment Combinations and Immunotherapy

Michael P. Chu, MD, Christopher P. Venner, MD, Irwindeep Sandhu, MD, Eva Baigorri, PhD, Jitra Kriangkum, PhD, Joanne D Hewitt, RN, BSN, NP, Andrew Belch, Linda M. Pilarski, PhD
Journal: Blood
Blood (2016) 128 (22): 2113.
https://doi.org/10.1182/blood.V128.22.2113.2113
Published: 2016
Journal Articles

Genomic Instability in Multiple Myeloma: Inducible Transfectants Provide a Model To Define the Role of RHAMM and Centrosome/Mitotic Spindle Stability in Myelomagenesis.

Brian J. Taylor, PhD, Eva Baigorri, MSc, Mary Hay, PhD, Tony Reiman, MD, Andrew R. Belch, MD, Linda M. Pilarski, PhD
Journal: Blood
Blood (2006) 108 (11): 5037.
https://doi.org/10.1182/blood.V108.11.5037.5037
Published: 2006